Apogee Therapeutics, Inc.APGENASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+97.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+97.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$214.71M+27.9%
2024$167.87M+145.3%
2023$68.42M+146.3%
2022$27.79M-